Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease

Background. It is known that disorders of the intestinal microbiota in patients with chronical liver disease (CLD) are associated with immune dysregulation. The process begins with a violation of the intestinal microbiota, leading to the development of immunodeficiency, affecting the course of the u...

Full description

Bibliographic Details
Main Authors: V.I. Didenko, O.M. Tatarchuk, E.V. Zygalo, I.S. Konenko, V.B. Yagmur
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2021-04-01
Series:Gastroenterologìa
Subjects:
Online Access:http://gastro.zaslavsky.com.ua/article/view/229433
_version_ 1819280707341516800
author V.I. Didenko
O.M. Tatarchuk
E.V. Zygalo
I.S. Konenko
V.B. Yagmur
author_facet V.I. Didenko
O.M. Tatarchuk
E.V. Zygalo
I.S. Konenko
V.B. Yagmur
author_sort V.I. Didenko
collection DOAJ
description Background. It is known that disorders of the intestinal microbiota in patients with chronical liver disease (CLD) are associated with immune dysregulation. The process begins with a violation of the intestinal microbiota, leading to the development of immunodeficiency, affecting the course of the underlying disease (with progression of liver fibrosis). Besides, violation of intestinal biocenosis is a consequence of adverse effects on the body and its microflora state resulting in reduced immune function. The purpose of the study was to determine the mechanisms of cytokine regulation in the body of patients with CLD in the formation and progression of liver fibrosis depending on the damage of the intestinal microbiota. Materials and methods. Seventy-six patients with CLD were examined. All patients underwent a hydrogen breath test (HBT), shear wave elastography; the liver stiffness parameters were studied on a FibroScan. Depending on the indices obtained and the presence of small intestinal bacterial overgrowth (SIBO) in the small intestine in the formation and progression of liver fibrosis, the patients were divided into groups. The subpopulation of lymphocytes — CD4 and CD8 was determined using monoclonal antibodies from the company “Sorbent TM”. The serum level of IL-6, IL-10, TNF-α was determined by enzyme-linked immunosorbent assay (ELISA) using the reagent kits from the company “Vector-BEST”. Results. The elevated levels of inflammatory cytokines (IL-6 and TNF-α) do not induce the secretion of anti-inflammatory cytokines (IL-10) with the presence of SIBO, which leads to the maintenance of inflammation and progression of liver fibrosis depending on intestinal biocenosis (a correlation was found between liver stiffness and hydrogen levels r = 0.79; р < 0.001). In patients with CLD, the violation of the cellular component of immunity is associated with an impairment of the intestinal microbiota, as evidenced by correlations with the hydrogen level (ppm): CD8+ (r = –0.439; p < 0.05) and CD4/CD8 (r = +0.492; p < 0.05). Conclusions. Impaired immunoregulatory mechanisms contribute to the fibrotic processes with subsequent violation of the gut microbiota.
first_indexed 2024-12-24T00:48:04Z
format Article
id doaj.art-93b70aba2e8243babeb9c78a9e33d1ba
institution Directory Open Access Journal
issn 2308-2097
2518-7880
language English
last_indexed 2024-12-24T00:48:04Z
publishDate 2021-04-01
publisher Zaslavsky O.Yu.
record_format Article
series Gastroenterologìa
spelling doaj.art-93b70aba2e8243babeb9c78a9e33d1ba2022-12-21T17:23:39ZengZaslavsky O.Yu.Gastroenterologìa2308-20972518-78802021-04-01551263110.22141/2308-2097.55.1.2021.229433266993Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver diseaseV.I. Didenko0O.M. Tatarchuk1E.V. Zygalo2https://orcid.org/0000-0001-5026-0992I.S. Konenko3V.B. Yagmur4https://orcid.org/0000-0002-1738-4624SI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, UkraineSI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, UkraineSI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, UkraineSI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, UkraineSI “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, UkraineBackground. It is known that disorders of the intestinal microbiota in patients with chronical liver disease (CLD) are associated with immune dysregulation. The process begins with a violation of the intestinal microbiota, leading to the development of immunodeficiency, affecting the course of the underlying disease (with progression of liver fibrosis). Besides, violation of intestinal biocenosis is a consequence of adverse effects on the body and its microflora state resulting in reduced immune function. The purpose of the study was to determine the mechanisms of cytokine regulation in the body of patients with CLD in the formation and progression of liver fibrosis depending on the damage of the intestinal microbiota. Materials and methods. Seventy-six patients with CLD were examined. All patients underwent a hydrogen breath test (HBT), shear wave elastography; the liver stiffness parameters were studied on a FibroScan. Depending on the indices obtained and the presence of small intestinal bacterial overgrowth (SIBO) in the small intestine in the formation and progression of liver fibrosis, the patients were divided into groups. The subpopulation of lymphocytes — CD4 and CD8 was determined using monoclonal antibodies from the company “Sorbent TM”. The serum level of IL-6, IL-10, TNF-α was determined by enzyme-linked immunosorbent assay (ELISA) using the reagent kits from the company “Vector-BEST”. Results. The elevated levels of inflammatory cytokines (IL-6 and TNF-α) do not induce the secretion of anti-inflammatory cytokines (IL-10) with the presence of SIBO, which leads to the maintenance of inflammation and progression of liver fibrosis depending on intestinal biocenosis (a correlation was found between liver stiffness and hydrogen levels r = 0.79; р < 0.001). In patients with CLD, the violation of the cellular component of immunity is associated with an impairment of the intestinal microbiota, as evidenced by correlations with the hydrogen level (ppm): CD8+ (r = –0.439; p < 0.05) and CD4/CD8 (r = +0.492; p < 0.05). Conclusions. Impaired immunoregulatory mechanisms contribute to the fibrotic processes with subsequent violation of the gut microbiota.http://gastro.zaslavsky.com.ua/article/view/229433immunoregulation, inflammatory process, liver fibrosis, intestinal microbiota, syndrome of intestinal bacterial overgrowth, inflammatory and anti-inflammatory cytokines, chronic diffuse liver disease
spellingShingle V.I. Didenko
O.M. Tatarchuk
E.V. Zygalo
I.S. Konenko
V.B. Yagmur
Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
Gastroenterologìa
immunoregulation, inflammatory process, liver fibrosis, intestinal microbiota, syndrome of intestinal bacterial overgrowth, inflammatory and anti-inflammatory cytokines, chronic diffuse liver disease
title Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
title_full Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
title_fullStr Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
title_full_unstemmed Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
title_short Impact of immune cell, state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
title_sort impact of immune cell state of cytokine regulation and intestinal biocenosis on the fibrotic processes in chronic diffuse liver disease
topic immunoregulation, inflammatory process, liver fibrosis, intestinal microbiota, syndrome of intestinal bacterial overgrowth, inflammatory and anti-inflammatory cytokines, chronic diffuse liver disease
url http://gastro.zaslavsky.com.ua/article/view/229433
work_keys_str_mv AT vididenko impactofimmunecellstateofcytokineregulationandintestinalbiocenosisonthefibroticprocessesinchronicdiffuseliverdisease
AT omtatarchuk impactofimmunecellstateofcytokineregulationandintestinalbiocenosisonthefibroticprocessesinchronicdiffuseliverdisease
AT evzygalo impactofimmunecellstateofcytokineregulationandintestinalbiocenosisonthefibroticprocessesinchronicdiffuseliverdisease
AT iskonenko impactofimmunecellstateofcytokineregulationandintestinalbiocenosisonthefibroticprocessesinchronicdiffuseliverdisease
AT vbyagmur impactofimmunecellstateofcytokineregulationandintestinalbiocenosisonthefibroticprocessesinchronicdiffuseliverdisease